《大行報告》大摩:裕元(00551.HK)最壞時間或過 毛利仍有改善空間
摩根士丹利發表報告表示,裕元集團(00551.HK)第三季表現遜預期,主因旗下越南廠房生產因疫情受阻,但利潤仍有增長空間,相信公司管理層的執行力仍是解鎖公司估值的主要因素,料最壞時間或已過去,維持對其「與大市同步」評級,目標價18元。
該行指,目前裕元集團已有逾70%產能復甦,料於今年年底可見回覆正常,目標在將毛利增加至20%。而公司旗下寶勝國際(03813.HK),目標經營溢利7%仍未達到,整體在生產有序復甦下,相信下行空間有限,但仍需時看公司達標能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.